Ahrum Min

Seoul, Republic of Korea

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications

DNA Damage and Nuclear Anaplasia Induced by Trastuzumab Deruxtecan in Cancer Cells with Variable HER2 Expression and Homologous Recombination Deficiency Status.

DNA Damage and Nuclear Anaplasia Induced by Trastuzumab Deruxtecan in Cancer Cells with Variable HER2 Expression and Homologous Recombination Deficiency Status.

Journal: Cancer research and treatment
Published: February 21, 2025

Cyclin dependent kinase 9 inhibitor induces transcription-replication conflicts and DNA damage accumulation in breast cancer.

Cyclin dependent kinase 9 inhibitor induces transcription-replication conflicts and DNA damage accumulation in breast cancer.

Journal: Cancer cell international
Published: January 27, 2025

Elimusertib, a Novel ATR Inhibitor, Induces Anti-tumor Effects through Replication Catastrophe in Breast Cancers.

Elimusertib, a Novel ATR Inhibitor, Induces Anti-tumor Effects through Replication Catastrophe in Breast Cancers.

Journal: Cancer research and treatment
Published: December 06, 2024

Establishment and characterization of 24 breast cancer cell lines and 3 breast cancer organoids reveals molecular heterogeneity and drug response variability in malignant pleural effusion-derived models.

Establishment and characterization of 24 breast cancer cell lines and 3 breast cancer organoids reveals molecular heterogeneity and drug response variability in malignant pleural effusion-derived models.

Journal: Breast cancer research : BCR
Published: November 18, 2024

Longitudinal multi-omics study of palbociclib resistance in HR-positive/HER2-negative metastatic breast cancer.

Longitudinal multi-omics study of palbociclib resistance in HR-positive/HER2-negative metastatic breast cancer.

Journal: Genome medicine
Published: October 24, 2022

DNA Damage Repair Inhibitor for Breast Cancer Treatment.

DNA Damage Repair Inhibitor for Breast Cancer Treatment.

Journal: Advances in experimental medicine and biology
Published: May 13, 2021

Predictive biomarkers for 5-fluorouracil and oxaliplatin-based chemotherapy in gastric cancers via profiling of patient-derived xenografts.

Predictive biomarkers for 5-fluorouracil and oxaliplatin-based chemotherapy in gastric cancers via profiling of patient-derived xenografts.

Journal: Nature communications
Published: October 12, 2020

Genomic profile of metastatic breast cancer patient-derived xenografts established using percutaneous biopsy.

Genomic profile of metastatic breast cancer patient-derived xenografts established using percutaneous biopsy.

Journal: Journal of translational medicine
Published: May 04, 2020

Homologous repair deficiency score for identifying breast cancers with defective DNA damage response.

Homologous repair deficiency score for identifying breast cancers with defective DNA damage response.

Journal: Scientific reports
Published: January 29, 2020

TDP1 and TOP1 Modulation in Olaparib-Resistant Cancer Determines the Efficacy of Subsequent Chemotherapy.

TDP1 and TOP1 Modulation in Olaparib-Resistant Cancer Determines the Efficacy of Subsequent Chemotherapy.

Journal: Cancers
Published: December 31, 2019

PARP Inhibitors as Therapeutics: Beyond Modulation of PARylation.

PARP Inhibitors as Therapeutics: Beyond Modulation of PARylation.

Journal: Cancers
Published: December 30, 2019

Prognostic Role of Androgen Receptor Expression in Surgically Resected Early Breast Cancer Patients.

Prognostic Role of Androgen Receptor Expression in Surgically Resected Early Breast Cancer Patients.

Journal: Journal of breast cancer
Published: December 16, 2019
Showing 1-12 of 32

Last Updated: 09/26/2026